Thus, the RCC cells retain their epithelial phenotype characterized by neither a decrease of CDH1 nor an increase of MMP2 in the presence of TGF-β1 and the inhibitor (Figure 7A, 7B). This evidence concerns the gene TGFB1 and renal cell carcinoma.